219 related articles for article (PubMed ID: 16516157)
1. Complement C3c and related protein biomarkers in amyotrophic lateral sclerosis and Parkinson's disease.
Goldknopf IL; Sheta EA; Bryson J; Folsom B; Wilson C; Duty J; Yen AA; Appel SH
Biochem Biophys Res Commun; 2006 Apr; 342(4):1034-9. PubMed ID: 16516157
[TBL] [Abstract][Full Text] [Related]
2. Biomarkers of neurodegenerative disorders: how good are they?
Rachakonda V; Pan TH; LE WD
Cell Res; 2004 Oct; 14(5):347-58. PubMed ID: 15538967
[TBL] [Abstract][Full Text] [Related]
3. Elevated serum autoantibody against high mobility group box 1 as a potent surrogate biomarker for amyotrophic lateral sclerosis.
Hwang CS; Liu GT; Chang MD; Liao IL; Chang HT
Neurobiol Dis; 2013 Oct; 58():13-8. PubMed ID: 23639787
[TBL] [Abstract][Full Text] [Related]
4. [The most probable clinical diagnosis to the applicants for the intractable disease registration of Parkinson's disease, spinocerebellar degeneration and amyotrophic lateral sclerosis].
Narita Y; Taniguchi A; Kuzuhara S
Rinsho Shinkeigaku; 2006 Mar; 46(3):193-8. PubMed ID: 16642929
[TBL] [Abstract][Full Text] [Related]
5. Proteome analysis reveals candidate markers of disease progression in amyotrophic lateral sclerosis (ALS).
Brettschneider J; Lehmensiek V; Mogel H; Pfeifle M; Dorst J; Hendrich C; Ludolph AC; Tumani H
Neurosci Lett; 2010 Jan; 468(1):23-7. PubMed ID: 19853641
[TBL] [Abstract][Full Text] [Related]
6. Protein biomarkers for amyotrophic lateral sclerosis.
Ryberg H; Bowser R
Expert Rev Proteomics; 2008 Apr; 5(2):249-62. PubMed ID: 18466055
[TBL] [Abstract][Full Text] [Related]
7. 2D gel blood serum biomarkers reveal differential clinical proteomics of the neurodegenerative diseases.
Sheta EA; Appel SH; Goldknopf IL
Expert Rev Proteomics; 2006 Feb; 3(1):45-62. PubMed ID: 16445350
[TBL] [Abstract][Full Text] [Related]
8. Quantitative proteomic analysis of serum proteins in patients with Parkinson's disease using an isobaric tag for relative and absolute quantification labeling, two-dimensional liquid chromatography, and tandem mass spectrometry.
Zhang X; Yin X; Yu H; Liu X; Yang F; Yao J; Jin H; Yang P
Analyst; 2012 Jan; 137(2):490-5. PubMed ID: 22108571
[TBL] [Abstract][Full Text] [Related]
9. [Leukotrienes and neurological diseases].
Irkeç C; Ercan S; Irkeç M
Mikrobiyol Bul; 1989 Oct; 23(4):342-7. PubMed ID: 2488942
[TBL] [Abstract][Full Text] [Related]
10. Biomarkers for Parkinson's [corrected] disease: tools to assess Parkinson's disease onset and progression.
Marek K; Jennings D; Tamagnan G; Seibyl J
Ann Neurol; 2008 Dec; 64 Suppl 2():S111-21. PubMed ID: 19127587
[TBL] [Abstract][Full Text] [Related]
11. Biomarker identification in human pancreatic cancer sera.
Hanas JS; Hocker JR; Cheung JY; Larabee JL; Lerner MR; Lightfoot SA; Morgan DL; Denson KD; Prejeant KC; Gusev Y; Smith BJ; Hanas RJ; Postier RG; Brackett DJ
Pancreas; 2008 Jan; 36(1):61-9. PubMed ID: 18192883
[TBL] [Abstract][Full Text] [Related]
12. Levels of complement components iC3b, C3c, C4, and SC5b-9 in peritoneal fluid and serum of infertile women with endometriosis.
Kabut J; Kondera-Anasz Z; Sikora J; Mielczarek-Palacz A
Fertil Steril; 2007 Nov; 88(5):1298-303. PubMed ID: 17482181
[TBL] [Abstract][Full Text] [Related]
13. Circulating antibodies to cysteinyl catecholamines in amyotrophic lateral sclerosis and Parkinson's disease patients.
Salauze L; van der Velden C; Lagroye I; Veyret B; Geffard M
Amyotroph Lateral Scler Other Motor Neuron Disord; 2005 Dec; 6(4):226-33. PubMed ID: 16319026
[TBL] [Abstract][Full Text] [Related]
14. Neuronal pentraxin receptor in cerebrospinal fluid as a potential biomarker for neurodegenerative diseases.
Yin GN; Lee HW; Cho JY; Suk K
Brain Res; 2009 Apr; 1265():158-70. PubMed ID: 19368810
[TBL] [Abstract][Full Text] [Related]
15. Biomarkers for Parkinson's disease.
Graeber MB
Exp Neurol; 2009 Apr; 216(2):249-53. PubMed ID: 19166835
[TBL] [Abstract][Full Text] [Related]
16. Amyloid P component as a plasma marker for Parkinson's disease identified by a proteomic approach.
Chen HM; Lin CY; Wang V
Clin Biochem; 2011 Apr; 44(5-6):377-85. PubMed ID: 21223953
[TBL] [Abstract][Full Text] [Related]
17. Serum and cerebrospinal fluid biochemical markers of ALS.
Shaw PJ; Williams R
Amyotroph Lateral Scler Other Motor Neuron Disord; 2000 Jun; 1 Suppl 2():S61-7. PubMed ID: 11464944
[TBL] [Abstract][Full Text] [Related]
18. Biomarkers in Parkinson's disease.
Dorsey ER; Holloway RG; Ravina BM
Expert Rev Neurother; 2006 Jun; 6(6):823-31. PubMed ID: 16784406
[TBL] [Abstract][Full Text] [Related]
19. Sporadic Parkinson disease and amyotrophic lateral sclerosis complex (Brait-Fahn-Schwartz disease).
Manno C; Lipari A; Bono V; Taiello AC; La Bella V
J Neurol Sci; 2013 Mar; 326(1-2):104-6. PubMed ID: 23380453
[TBL] [Abstract][Full Text] [Related]
20. High levels of C3c in the cerebrospinal fluid from amyotrophic lateral sclerosis patients.
Annunziata P; Volpi N
Acta Neurol Scand; 1985 Jul; 72(1):61-4. PubMed ID: 4050318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
